1 week Ago
DUBLIN , March 26, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 24 th Annual Needham Healthcare Conference. Company management will participate in a fireside chat on Wednesday, April 9, 2025 , at 9:45 a.m.
PT / 12:45 p.m. ET / 5:45 p.
m. IST . An audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.
jazzpharma.com/investors/events-presentations . A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments.
Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.
jazzpharmaceuticals.com for more information. Contacts: Investors: Jeff Macdonald Executive Director, Investor Relations Jazz Pharmaceuticals plc InvestorInfo@jazzpharma.
com Ireland +353 1 634 3211 U.S. +1 650 496 2717 Media: Kristin Bhavnani Head of Global Corporate Communications Jazz Pharmaceuticals plc CorporateAffairsMediaInfo@jazzpharma.
com Ireland +353 1 637 2141 U.S. +1 215 867 4948 Logo - https://mma.
prnewswire.com/media/272253/Jazz_Pharmaceuticals_New_Logo.jpg.
